Physician 360 is a technology company.
Physician 360 has raised $400K across 1 funding round.
Physician 360 has raised $400K in total across 1 funding round.
Physician 360 (now myphysician360) is a digital health platform offering telemedicine and at-home diagnostic testing for common conditions like strep, flu, UTI, anemia, ear infections, and more, enabling independent pharmacies to function as virtual urgent care clinics.[1][2][3][4] It serves patients seeking convenient, affordable care—often under $50 per visit—through pharmacy pickups, self-tests, and virtual consultations with board-certified physicians, primarily targeting rural and underserved areas while partnering with over 3,000 independent pharmacies across all 50 states.[2][4] The company solves long ER waits, high copays, and diagnostic delays by combining point-of-care testing with telemedicine, empowering pharmacies to expand services without complex agreements.[1][3]
Growth momentum includes expansion from 24-38 states to nationwide availability, a 2024 rebrand to myphysician360, new leadership hires like CEO Michael Muchnicki and Chief Clinical Officer Betsy Warren, and a shift toward insurance acceptance.[1][2][4][6] Bootstrapped initially, it has opened a seed round and attracted Valor Ventures investment, positioning it for acquisitions by major players like CVS or Quest Diagnostics amid rising point-of-care trends.[1][3]
Physician 360 was co-founded by board-certified emergency medicine physicians Dr. Angela Fusaro and Dr. Rob Lapporte, who drew from real-world frustrations in ERs where patients endured six-hour waits for simple diagnoses like viruses, only to face high costs and disappointment.[1][3] Fusaro, still practicing part-time ER shifts for market insights, identified gaps in convenient, accurate alternatives for time-sensitive illnesses like flu, leading to the "virtual emergency room" concept: pharmacy-picked FDA-cleared test kits plus telemedicine for under $50.[3]
Launched around 2023, the Atlanta-based startup (headquartered in Southlake, Texas) quickly gained traction via B2B2C pharmacy partnerships, growing from 24 states to nationwide while remaining bootstrapped before a seed round.[1][3][4] Pivotal moments include Valor Ventures portfolio inclusion and adaptations like rebranding to myphysician360 in January 2024 to emphasize rural access.[1][4][6]
Physician 360 rides the convergence of telemedicine growth, point-of-care testing, and pharmacy expansion, fueled by patient demands for shorter visits, pharmacist service growth, and post-pandemic virtual care adoption.[1][3] Timing aligns with commercial labs (Quest, LabCorp) losing ground to in-office/at-home tests, while major chains like CVS, Walgreens, and Rite Aid acquire accessibility plays—positioning Physician 360 as an ideal target.[1]
It influences the ecosystem by democratizing urgent care for rural/underserved populations, enabling independents to compete with chain clinics, and bridging digital health with physical pharmacies for hybrid models.[4] This counters ER overload and high costs, tapping a large market where independent pharmacies hold 40% share.[1][2]
Physician 360 is poised for accelerated growth through insurance adoption, team scaling via seed funding, and national pharmacy saturation, potentially hitting acquisition by 2026 amid M&A activity in diagnostics.[1][3][7] Trends like AI-enhanced telehealth, expanded pharmacist scopes, and rural health mandates will amplify its edge, evolving it from bootstrapped innovator to ecosystem leader. As founders' ER-honed vision scales, it redefines convenient care—proving a "virtual emergency room" can outpace traditional waits, much like its origins in those very frustrations.
Physician 360 has raised $400K in total across 1 funding round.
Physician 360's investors include Turtle Ventures, ValorVC.
Physician 360 has raised $400K across 1 funding round. Most recently, it raised $400K Seed in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $400K Seed | Turtle Ventures, ValorVC |